‘We've got your back': WASHS students focus on suicide prevention
The WASHS Aevidum Club hosted its third Aevidum Strides Against Stigma on May 8.
Coming up on May 24: 'Tangled' is the theme of Waynesboro Area Senior High School prom
Aevidum is Latin for 'I've got your back,' according to Amanda Eddy, a WASHS counselor and club adviser.
The Waynesboro club is part of a national organization which, according to its website, 'empowers youth to shatter the silence surrounding depression, suicide and other issues facing teens … Aevidum inspires schools and communities to adopt cultures of care and advocacy, encouraging all members to have their friends' backs.'
The club was formed at WASHS after several students committed suicide and 'we knew something had to change,' Eddy said. The club grew out of the idea that students are often more likely to talk to each other rather than adults.
The club is 'focused on shattering the stigma and shedding light on mental health awareness,' Eddy said. 'Suicide prevention is our overall goal.'
Brianna Nickel, now a senior and Aevidum treasurer, helped start the club. She remembers thinking, 'What can we do to make sure this does not happen again?'
She was one of the club members wearing yellow T-shirts that said 'We've Got Your Back' at the Aevidum Strides Against Stigma.
They handed out cards with stress release tips as the school year comes to an end with lots of testing. Club members also shared mental health facts as 'commercial breaks' while their fellow students took Strides Against Stigma on the track, where signs like this were displayed on the fence:
'You are loved. You are worthy. You are enough.'
'One step at a time. You can make it through. Progress, not perfection.'
'It's never too late to start prioritizing your mental health.'
The 'brain break' included fun components like face-painting, bracelet making, games and the popular 'Dunk the Teacher.'
This article originally appeared on Waynesboro Record Herald: Waynesboro Area Senior High School Aevidum Club promotes mental health
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
7 days ago
- Business Wire
RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)
SENDAI, Japan--(BUSINESS WIRE)--RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform, called ai Protein ® has announced its participation in a research and development program funded by a government grant of 54 million JPY (approximately US$372K for the first year) from the Japanese Agency for Medical Research and Development (AMED). This project, set to continue over 4 years, is led by Prof. Mitsuo Umetsu of Tohoku University, who also serves as RevolKa's Chief Scientific Officer. This opportunity will further accelerate RevolKa's rare disease drug discovery and development efforts, previously announced on July 30 th, 2024. ( RevolKa's core technology, ai Protein ®: a robust directed protein evolution platform integrated with AI (artificial intelligence) creates exceptionally high performance proteins, going beyond natural evolution and offering advantages for therapeutic strategies. ai Protein ® has generated many successful outcomes with many partner companies. About ai Protein ® Technology RevolKa's proprietary technology, ai Protein ® is an AI-assisted directed evolution platform for proteins. Naturally occurring proteins are linear polymers composed of amino acids and their derivatives, folding into a tertiary structure through internal complex atomic interactions to exhibit biological functions. Proteins have evolved their biological functional complexity over hundreds of millions of years. However, the relationship between protein sequence, structure, and function remains poorly understood to enable rational design of protein sequences for specific function. RevolKa's AI engine is trained with sequence-function relationship data, enabling statistical prediction of optimized protein sequences with desired functions. Furthermore, ai Protein ® can evolve multiple properties simultaneously. This technology is a powerful and cost-effective solution for creating novel and highly functional proteins suitable for pharmaceutical and industrial applications. About RevolKa Ltd. RevolKa is a venture-backed biotechnology company founded in April 2021 by academic and industry experts in biotechnology and artificial intelligence. Our mission is to contribute to human well-being by creating novel proteins for therapeutics and industrial applications using our proprietary technology, ai Protein®. The name "RevolKa" is derived from the Latin word for evolution, "evolutio' and the Ainu (an indigenous Japanese people) word for raise, 'reska'. RevolKa's headquarters and laboratories are located in Sendai, Japan. The company's investors include D3 LLC, Tohoku University Venture Partners Co., Ltd., DEEPCORE Inc., and SBI Investment Co., Ltd. For more information, visit
Boston Globe
23-06-2025
- Boston Globe
A cutting-edge cancer therapy offers hope for patients with lupus
By fall of 2024, Le had run out of conventional treatment options. That's when Dr. Meghan Sise, her physician, offered her a chance to participate in a clinical trial that was testing a new therapy, borrowed from the field of cancer research. 'Let's try it,' Le told Sise, who is a principal investigator on the trial. 'I have nothing to lose.' Advertisement CAR T-cell therapy, a kind of 'living drug' that modifies patients' immune cells to help them attack misbehaving ones, has been used with significant success to treat some cancers, particularly of the blood. A growing body of evidence has suggested that the therapy can also treat a severe form of lupus that, at best, can be managed as a lifelong condition and, at worst, resists treatment and can lead to organ failure and death. 'It's really promising, and honestly the first therapy that we've talked about as a cure,' said Dr. Lisa Sammaritano, a rheumatologist at the Hospital for Special Surgery — Weill Cornell Medicine and the lead author on a set of recently updated guidelines for lupus treatment. Until now, she said, 'we haven't had a cure — we've had control.' Advertisement Whether this is truly a cure, and for whom, remains to be seen. Clinical trials for patients with severe disease are still in early phases, and CAR T-cell therapy, which must be personalized to each patient, is extraordinarily expensive. 'I'm hoping that it is a common future therapy,' Sammaritano said, 'but we're not at the point yet where we can say that with confidence.' Lupus, or systemic lupus erythematosus, is an autoimmune condition in which the body develops antibodies against its own DNA and other cellular material. The name derives from the Latin for 'wolf' because the skin lesions the disease sometimes causes were once thought to resemble wolf bites, some say. The disease can cause joint pain, rashes, severe fatigue and inflammation in organs, said Dr. April Barnado, a rheumatologist and assistant professor of medicine at Vanderbilt University Medical Center. Typically, symptoms first appear between ages 15 and 44. Of the estimated 3 million people with lupus worldwide, 90 percent are women. Lupus often strikes 'at a time when women are raising families, or they're caregiving, or they're trying to get promoted at work,' Barnado said. 'They wake up and feel like they have the flu or a viral infection a few days a week every week. That's pretty debilitating.' A patient's symptoms can flare up in response to a trigger like stress or an infection. Le, for example, would wind up in the emergency room every few months with a severe rash, joint swelling, and pain and sores in her mouth. She would pass out for hours from exhaustion. Advertisement 'It would take me two months to get healed back to normal,' Le said. She frequently had to take medical leave from her job. Le is among the roughly 50 percent of lupus patients who have inflammation in their kidneys, a condition known as lupus nephritis. Between 10 percent and 30 percent of these patients will eventually need dialysis or a kidney transplant, said Sise, the director of onconephrology at Massachusetts General Hospital. Treatment usually involves steroids and immunosuppressive drugs. Steroids tamp down inflammation, but they carry major risks with long-term use, including cardiovascular disease and osteoporosis. 'Nothing can bring the symptoms under control more quickly,' Sammaritano said, 'but the longer you stay on it, the more the side effects.' Newer drugs that target specific parts of the immune system are less harmful, but patients often require treatment for decades, and many still won't be able to get their disease under control. With the rise of CAR T-cell therapy in oncology, Dr. Georg Schett, a rheumatologist and immunologist at the University of Erlangen in Germany, started mulling a new idea to help lupus patients. Lupus causes the body's B cells — white blood cells that produce antibodies — to go haywire. In CAR T-cell therapy, a patient's own T cells, a type of immune cell, are extracted and engineered to wipe out disease-causing B cells. They're then put back in the body, where they replicate, acting like 'serial killers' that can clear out B cells even from deep within tissues that other drugs can't reach, Schett said. Advertisement Perhaps most tantalizing to Schett was the idea that a single infusion might do the trick, freeing young women from the constraints, and uncertainty, of living with lupus. 'The disease dominates their life,' he said. Janina Paech, a medical student in Cologne, Germany, was among the first to receive the treatment. Paech was diagnosed with lupus in 2015, at age 16. She developed a severe rash anytime she went out in the sun. Her joints ached. Her hair fell out. And she was so fatigued that she slept most of the day and night. With steroids and immunosuppressive drugs, Paech went into remission. But she had high blood pressure, more hair loss and so much swelling it gave her a 'moon face' — all side effects of the medications. Her thinned skin caused extreme sensitivity and pain. Despite treatment, Paech had flare-ups of lupus amid the stress of medical school. Eventually, her kidneys and other organs started to fail. Paech's father reached out to Schett, whom he had read about in a newspaper. Paech received the CAR T cells in 2021, and within days, her symptoms retreated. They still haven't returned. Since then, dozens of patients worldwide have been treated with the therapy, which has not yet been approved for lupus by the Food and Drug Administration. The therapy has risks, including the possibility of systemic inflammation that can cause high fever and, rarely, neurological symptoms. Dr. Carl June, a professor of immunotherapy at the University of Pennsylvania and a pioneer of CAR T-cell therapy, said that its potential for treating lupus and other autoimmune diseases was apparent to him early on. But it was the technology's use in cancer treatment that really 'paved the way' to start testing it in other conditions, he said. Advertisement The treatment is still prohibitively expensive, with one-time costs for approved cancer therapies approaching $500,000 or more. And researchers don't yet know how patients will fare in the long run. 'The big question is: How long does it last? Are they cured?' June said. A recent large trial of CAR T-cell therapy for multiple myeloma found that one-third of patients remained in remission five years after therapy, though other studies have shown median survival times after treatment ranging from a few months to a couple of years. Of the two dozen lupus patients Schett has treated, all but one went into remission and remained off treatment after at least six months, and some for longer than four years. (One patient who had a relapse underwent CAR T-cell therapy a second time and is now symptom-free.) It will be years before doctors know for sure whether those results can last. In the meantime, patients say the treatment has given them an opportunity to live a normal life. 'I get to be more careless,' Paech said. 'That was something that was very hard for me to learn because I didn't learn it as a young adult.' Before the treatment, she couldn't travel for fear of getting sick and needing to carry medications around. But Paech has now been able to visit Egypt, South Africa and Australia. Even when her lupus was controlled with steroids, she said, she felt well enough to do only one activity a day. 'I could go to the mall and that was it — I couldn't do anything else,' she recalled. 'Now going to the mall is like one out of 10 things in the day.' Advertisement Le has been able to return to her job at a factory and can now get a good night's sleep before waking up to start work at 5 a.m. (She used to wake several times a night to urinate because of her kidney disease.) Pain-free and more energetic, she can now take long walks and lift heavy grocery bags. She also hopes to try to conceive later this year. Before her treatment, Le often answered 'yes' to many of the symptoms on Sise's checklist, a reflection of how debilitating her condition had become. But on her recent visit in May, six months after she received CAR T-cell therapy, she answered 'no' to every question. This article originally appeared in .
Yahoo
09-06-2025
- Yahoo
When is the next full moon and does it really affect your health?
The next full moon – known as the Strawberry Moon – will appear on 10 June, peaking the following morning. It's not named for its colour, but because it marks the start of wild strawberry season. Some people say the full moon messes with their sleep, mood or energy. And it's not just superstition – scientists are now looking into whether lunar phases can influence things like sleep, hormones, heart health and mental wellbeing. So, is there anything in it? Here's what we know – and how to feel your best when the moon rolls around. Despite the name, the Strawberry Moon doesn't actually turn pink. The nickname comes from Native American and European traditions that tied full moons to seasonal events – in this case, the strawberry harvest. You might also hear it called the Rose Moon, Honey Moon or Mead Moon, depending on where in the world you are. This year's Strawberry Moon will be particularly striking. It's the lowest-hanging full moon of 2025 in the Northern Hemisphere, which means it will look bigger and more golden as it rises at dusk. No telescope needed – just head outside and look up. The idea that the moon impacts our health has been around for centuries. While not all of it is backed by stats (and results are often mixed), scientists are starting to dig deeper into potential connections. Here's what some of the research says: A 2013 study from the University of Basel found people took longer to fall asleep, got 30% less deep sleep, and slept about 20 minutes less during a full moon, even in controlled rooms without light or clocks. More recently, researchers at the University of Washington found a similar pattern: people went to bed later and slept less in the days leading up to a full moon, no matter where they lived or whether they had electric lighting. It means since moonlight and bedtime habits were ruled out, something else might be at play, in this case, maybe our body's own rhythm responding to the lunar cycle. The average menstrual cycle lasts around 28 to 30 days – similar to the lunar cycle – so it's no surprise the two have long been linked. In fact, the word 'menstruation' shares roots with the Greek word for moon (mene) and the Latin for month (mensis). A small 1980 study did find that some women were more likely to start their periods around the new moon. But a large-scale analysis from 2017 by period-tracking app Clue, covering more than 7.5 million cycles, found no consistent link between period start dates and moon phases. Studies on the moon's impact on heart health have been mixed. A 2021 Japanese study found no link between moon phases and out-of-hospital cardiac arrests. However, a small 2013 study reported that blood pressure readings were slightly lower during full and new moons – suggesting a subtle effect on circulation. The idea that the moon affects our mood goes way back. The word 'luna' (Latin for moon) was even linked to emotional shifts in ancient times. Modern research, though, doesn't show a clear link. A 2017 study in psychiatry reported no significant rise in mental health issues during different moon phases. That said, research suggests people with conditions like bipolar disorder may be more sensitive to sleep disruptions, which, as we've seen, can happen around the full moon. So if you have mood changes, it's less likely due to the moon and could be more about the knock-on effects of poorer rest. Even if you're not usually moon-sensitive, there's no harm in building a few easy habits around the full moon, especially if it helps you feel more balanced and better rested. Wind down early. Try switching off a bit sooner in the evenings before the full moon. Even 15 minutes can help signal to your brain it's time to relax. Block out the glow. Blackout curtains or an eye mask can support melatonin production, the hormone that helps you sleep. Move your body. A little gentle exercise during the day (like walking or yoga) can help regulate sleep and release stress. Skip the caffeine – or cut back after 2pm. It can sneakily mess with your sleep, even if you feel fine. Track patterns: If you notices changes, jot down how you feel during different moon phases. You might be more in sync than you realise. Read more: Strawberry moon to rise over Britain next week, but it will be in an odd place (Yahoo News UK, 3-min read) What It Means to Get Your Period on a Full Moon (21 Ninety, 3-min read) What is 'moon breathing'? The ancient technique that promises to help you fall asleep (New York Post, 3-min read)
